New study aims to personalize throat cancer treatment using blood and MRI
NCT ID NCT07407205
First seen Feb 14, 2026 · Last updated May 20, 2026 · Updated 13 times
Summary
This study looks at whether special blood tests (like tumor DNA) and MRI scans can predict how well chemoradiotherapy works for people with HPV-negative throat cancer. Researchers will follow 30 patients to see if these markers can help doctors choose the best treatment and reduce the number of scans needed after treatment. The goal is to make follow-up care simpler and more personalized.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OROPHARYNGEAL SQUAMOUS CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Institute of Oncology Ljubljana
Ljubljana, 1000, Slovenia
Conditions
Explore the condition pages connected to this study.